Leiner OTC Sales Jump Nearly 30% On New Products, Manufacturing Promotions
This article was originally published in The Tan Sheet
Private labeler Leiner Health Products' OTC product sales increased by nearly 30% for its fiscal 2007 second quarter, driven largely by new product launches and promotions with manufacturing customers, COO Robert Reynolds said in a Nov. 14 analysts call
You may also be interested in...
Perrigo will take a $2.9 mil. earnings hit for recalling roughly 11 mil. bottles of acetaminophen after it found small metal fragments in some of the 500 mg caplets, the private labeler said
Leiner Health Products' strong sales in the joint care, coenzyme Q10 and fish oil categories produced a 12.6% boost to $163.9 mil. in net sales for the first quarter of fiscal 2007 (ended June 24, 2006), the firm announced in a first quarter earnings call Aug. 8
Leiner Health Products' gross profit margins continue to improve, with consolidated gross profit margin "returning" to 24.5% for the fourth quarter of fiscal 2006, CEO Robert Kaminski announced during a fourth-quarter and full-year earnings call June 15